2-cyclobutylacetic Acid → HCID 178520160, compound
Reaction equation
Cl.Cl.[O:3]1[C:7]2[CH:8]=[CH:9][CH:10]=[C:11]([CH:12]3[CH2:17][CH2:16][N:15]([CH2:18][CH2:19][C@H:20]4[CH2:25][CH2:24][C@H:23]([NH2:26])[CH2:22][CH2:21]4)[CH2:14][CH2:13]3)[C:6]=2[CH2:5][CH2:4]1.[CH:27]1([CH2:31][C:32](O)=[O:33])[CH2:30][CH2:29][CH2:28]1>>[CH:27]1([CH2:31][C:32]([NH:26][C@H:23]2[CH2:22][CH2:21][C@H:20]([CH2:19][CH2:18][N:15]3[CH2:16][CH2:17][CH:12]([C:11]4[C:6]5[CH2:5][CH2:4][O:3][C:7]=5[CH:8]=[CH:9][CH:10]=4)[CH2:13][CH2:14]3)[CH2:25][CH2:24]2)=[O:33])[CH2:30][CH2:29][CH2:28]1Participants
3
Procedure
The title compound, off-white solid (53 mg, 50%), MS (ISP) m/z=425.3 [(M+H)+], mp 196° C., was prepared in accordance with the general method of example 1 from trans-4-{2-[4-(2,3-dihydro-benzofuran-4-yl)-piperidin-1-yl]-ethyl}-cyclohexylamine dihydro chloride (intermediate B) (100 mg, 0.25 mmol) and 2-cyclobutyl-acetic acid.
Sources & evidence
- ORD record
- ord-4875f6708f4c4dbcae83836fe7718c06
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08877778B2
Reaction notes
Loading…